Trial
NCT02431221
Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
Phase IIIWITHDRAWNEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Heart Metabolics Limited
Collaborators
—
Condition
Hypertrophic Cardiomyopathy
Intervention
Perhexiline
Why stopped
Lack of efficacy in a preceding study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-14